1. Kang DY, Lee DI, Kim KH. Statistical studies on multiple myeloma in Korea-Preliminary report. Korean J Hematol 7:31. 1972.
2. Kang DY. Statistical studies on multiple myeloma in Korea-second report In : Fourth meeting, Asian-Pacific Division, International Society of Hematology; June 25:, 1979; (abstr).
3. Park MH. Multiple myeloma: Analysis on M-components of 65 cases. Korean J Hematol 18:181. 1983.
4. Durie BGM, Salmon SE. Multiple myeloma, macroglobulinaemia, and monoclonal gammopathies. In: Hoffbrand AV, Brain MC, Hirsch J, eds. Recent Advances in Haematology. Edinburgh: Churchill Livingstone, 1977;243.
5. Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842. 1975.
6. Case DC, Lee BJ III, Clarkson BD. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. Am J Med 63:897. 1977.
7. Chronic Leukemia-Myeloma Task Force, National Cancer Institute. Proposed guidelines for protocol studies II. Plasma cell myeloma. Cancer Chemother Rep 4:145. 1973.
8. Oken MM. Multiple myeloma. Med Clin Noth Am 68:757. 1984.
9. Minstry of Health and Social Affairs. One year report for Cancer Registry programme in the Republic of Korea (July 1, 1984–June 30, 1985). J Korean Cancer Res Assoc 18:59. 1986.
10. Kyle RA. Multiple myeloma: Review of 869 cases. Mayo Clin Proc 50:29. 1975.
11. Perri RT, Hebbel RP, Oken MM. Influence of treatment and response status on infection risk in multiple myeloma. Am J Med 71:935. 1981.
12. Santoro A. Clinical staging and therapeutic results in multiple myeloma. Eur J Cancer Clin Oncol 19:1353. 1983.
13. Raymond A, John B, Edmund G, Arthur H, James H, Montague L, Raymond M, Henry W. Combination chemotherapy for multiple myeloma. Cancer 30:382. 1972.
14. Alexanian R, Bergsagel DE, Migliore PJ, Vaughn WK, Howe CD. Melphalan therapy for plasma cell myeloma. Blood 31:1. 1968.
15. Rivers SL, Patno ME. Cyclophosphamide vs melphalan in the treatment of plasma cell myeloma. J Am Med Assoc 207:1328. 1969.
16. Alberts DS, Salmon SE. Adriamycin in the treatment of alkylator-resistant multiple myeloma. A pilot study. Cancer Chemother Rep 59:345. 1975.
17. Lee BJ, Lake-Lewin D, Myers JE. Intensive treatment of multiple myeloma. In: Wiernik PH, ed. Controversies in Oncology. New York: John Wiley and Sons, 1982;61.
18. Oken MM, Tsiatis A, Abramson N, Glick J. Comparison of standard MP with intensive VBMCP therapy for the treatment of multiple myeloma (MM). Proc Am Soc Clin Oncol 3:270. 1984;(abstr).
19. Alberts DS, Durie BGM. Doxorubicin and BCNU chemotherapy for multiple myeloma in relapse. Lancet 1:926. 1976.